EGR2 Targets Insulin Receptor Substrate 2 and Affects the Children's Type 1 Diabetes Progression In Vivo and In Vitro

Xiaofeng Sun, Jin Liu, Ji’ou Zhao, Gang Zhang, Wendi Zhou

PDF(31190 KB)
For Authors|For Editors|For Reviewers
PDF(31190 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (206) : 851-865. DOI: 10.24976/Discov.Med.202638206.70
Article

EGR2 Targets Insulin Receptor Substrate 2 and Affects the Children's Type 1 Diabetes Progression In Vivo and In Vitro

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(206): 851-865 https://doi.org/10.24976/Discov.Med.202638206.70

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(31190 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉